Related Experiment Video
Updated: Dec 29, 2025

12:33
A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
Published on: June 25, 2014
66.0K
Control-Oriented Model With Intra-Patient Variations for an Artificial Pancreas.
IEEE Journal of Biomedical and Health Informatics
|January 30, 2020
Summary
A new low-order model for Type 1 Diabetes Mellitus (T1DM) glucose regulation improves upon existing models. This personalized model enhances control system design for more reliable glycemia management.
Area of Science:
- Biomedical Engineering
- Control Systems
- Metabolic Modeling
Background:
- Type 1 Diabetes Mellitus (T1DM) management requires accurate glucose-insulin system modeling.
- Existing models face challenges with intra-patient variability and inter-subject differences.
- Control-oriented models are crucial for developing effective glucose regulation strategies.
Purpose of the Study:
- To develop a novel low-order, control-oriented model for T1DM glucose regulation.
- To capture nonlinear dynamics and intra-patient insulin sensitivity variations.
- To improve upon previous T1DM control models for enhanced personalization and robustness.
Main Methods:
- Utilized the UVA/Padova metabolic simulator to derive a low-order model.
- Incorporated intra-patient variability in insulin sensitivity (SI).
- Enabled model personalization using a priori patient information for Linear Parameter Varying (LPV) controller design.
- Evaluated model performance against a previous control-oriented model.
Main Results:
- The proposed model accurately represents subcutaneous glucose dynamics from insulin input.
- It effectively captures nonlinear system behavior and daily SI variations.
- Demonstrated superior performance compared to prior T1DM control-oriented models in open- and closed-loop simulations.
- Showed reduced differences compared to the UVA/Padova simulator.
Conclusions:
- The developed low-order model offers improved accuracy and personalization for T1DM glucose regulation.
- Its structure is suitable for advanced LPV controller design.
- This advancement holds potential for more robust and reliable glycemia control systems in T1DM patients.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Physiological Models
220
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
220
One-Compartment Open Model for IV Bolus Administration: General Considerations
615
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
615
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.0K

